• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒基因纤维化测试:一种结合病毒、肝脏和基因组(IL28b、ITPA、UGT1A1)生物标志物的方法,用于预测慢性丙型肝炎患者的治疗反应。

HCV-GenoFibrotest: a combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis C.

机构信息

Pasteur-Cerba, Cergy-Pontoise, France.

出版信息

Clin Res Hepatol Gastroenterol. 2011 Mar;35(3):204-13. doi: 10.1016/j.clinre.2011.01.005. Epub 2011 Feb 26.

DOI:10.1016/j.clinre.2011.01.005
PMID:21354889
Abstract

BACKGROUND AND AIM

Three gene polymorphisms, interferon-lambda-3 (IL28B), inosinetriphosphatase (ITPA) and bilirubinuridine diphosphate-glucuronosyltransferase (UGT1A1) are associated with treatment (interferon and ribavirin) efficacy and adherence in patients with chronic hepatitis C. The hypothesis was that fibrosis stage estimated with FibroTest instead of biopsy was still an independent predictive factor of sustained virologic response (SVR) when these new polymorphisms were assessed.

METHODS

Patients receiving standard of care treatment were retrospectively analyzed with determination of IL28B, ITPA, and UGT1A1 polymorphisms. Baseline prognostic factors were combined using logistic regression analysis in a training group (157 patients) and validated in avalidation group (79 patients).

RESULTS

The combination of the five most predictive factors (HCV genotype 2/3, IL28B genotype, FibroTest, ActiTest and viral load) in the training population had AUROC for SVR=0.743 (0.655-0.810; P<0.0001 vs. random), which was validated in the validation population, AUROC=0.753 (0.616-849; P=0.0007 vs. random, not different from training P=0.88). FibroTest remained significant [OR=4.20 (2.59-12.50); P=0.03] after assessment of the IL28B CC, HCV genotype and viral load.

CONCLUSION

Fibrosis stage assessed by FibroTest is an independent predictor of SVR, after accounting for the IL28B genetic polymorphism. A combination of five baseline biomarkers could simplify the baseline prediction of SVR.

摘要

背景和目的

三种基因多态性,干扰素-lambda-3(IL28B)、肌苷三磷酸酶(ITPA)和胆红素尿苷二磷酸葡萄糖醛酸转移酶(UGT1A1)与慢性丙型肝炎患者的治疗(干扰素和利巴韦林)疗效和依从性相关。假设在用 FibroTest 估计纤维化分期而不是进行肝活检时,当评估这些新的多态性时,它仍然是持续病毒学应答(SVR)的独立预测因素。

方法

对接受标准治疗的患者进行回顾性分析,确定 IL28B、ITPA 和 UGT1A1 多态性。使用逻辑回归分析在训练组(157 例患者)中联合确定基线预后因素,并在验证组(79 例患者)中进行验证。

结果

在训练人群中,将五个最具预测性的因素(HCV 基因型 2/3、IL28B 基因型、FibroTest、ActiTest 和病毒载量)组合起来,对 SVR 的 AUROC 为 0.743(0.655-0.810;P<0.0001 与随机对照相比),在验证人群中得到验证,AUROC=0.753(0.616-849;P=0.0007 与随机对照相比,与训练相比无差异,P=0.88)。在评估 IL28B CC、HCV 基因型和病毒载量后,FibroTest 仍然具有统计学意义[OR=4.20(2.59-12.50);P=0.03]。

结论

在考虑到 IL28B 遗传多态性后,FibroTest 评估的纤维化分期是 SVR 的独立预测因素。五种基线生物标志物的组合可以简化 SVR 的基线预测。

相似文献

1
HCV-GenoFibrotest: a combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis C.丙型肝炎病毒基因纤维化测试:一种结合病毒、肝脏和基因组(IL28b、ITPA、UGT1A1)生物标志物的方法,用于预测慢性丙型肝炎患者的治疗反应。
Clin Res Hepatol Gastroenterol. 2011 Mar;35(3):204-13. doi: 10.1016/j.clinre.2011.01.005. Epub 2011 Feb 26.
2
Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment.ITPA和IL28B基因变异在慢性丙型肝炎治疗管理中的作用。
Infez Med. 2015 Jun;23(2):134-9.
3
Prevalence of rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.rs4803217单核苷酸多态性的患病率与慢性丙型肝炎的临床病程
World J Gastroenterol. 2017 Jun 7;23(21):3815-3824. doi: 10.3748/wjg.v23.i21.3815.
4
Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection.IL28B 和肌苷三磷酸酶基因多态性在慢性丙型肝炎病毒基因型 6 感染治疗中的作用。
J Viral Hepat. 2013 Jul;20(7):470-7. doi: 10.1111/jvh.12047. Epub 2013 Apr 12.
5
IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C.IL28B 多态性、IP-10 和病毒载量可预测慢性丙型肝炎治疗的病毒学应答。
Aliment Pharmacol Ther. 2011 May;33(10):1162-72. doi: 10.1111/j.1365-2036.2011.04635.x. Epub 2011 Mar 28.
6
Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection.慢性丙型肝炎病毒感染的血液透析患者中低病毒载量的相关性。
World J Gastroenterol. 2015 May 14;21(18):5496-504. doi: 10.3748/wjg.v21.i18.5496.
7
Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.IL28B基因变异rs12979860和rs8099917对慢性丙型肝炎4型患者联合治疗病毒学应答的强大预测作用
Liver Int. 2014 Jul;34(6):890-5. doi: 10.1111/liv.12321. Epub 2013 Oct 14.
8
[Association of interleukin 28B polymorphisms with response to pegylatedinterferon plus ribavirin therapy for chronic hepatitis C].白细胞介素28B基因多态性与聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎疗效的相关性
Sichuan Da Xue Xue Bao Yi Xue Ban. 2012 Nov;43(6):855-9.
9
Roles of ITPA and IL28B genotypes in chronic Hepatitis C patients treated with peginterferon plus ribavirin in Tunisian population.ITPA 和 IL28B 基因型在聚乙二醇干扰素联合利巴韦林治疗的突尼斯慢性丙型肝炎患者中的作用。
J Clin Virol. 2015 Aug;69:184-9. doi: 10.1016/j.jcv.2015.06.102. Epub 2015 Jun 27.
10
Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.干扰素-λ基因多态性对慢性丙型肝炎治疗反应的预测价值
PLoS One. 2014 Nov 13;9(11):e112592. doi: 10.1371/journal.pone.0112592. eCollection 2014.

引用本文的文献

1
A Current Management Strategy for Children with Chronic Viral Hepatitis B, Based on International and National Guidelines.基于国际和国内指南的儿童慢性乙型肝炎病毒感染的现行管理策略。
J Mother Child. 2023 Aug 31;27(1):134-141. doi: 10.34763/jmotherandchild.20232701.d-23-00006. eCollection 2023 Jun 1.
2
Wall.ex DC in Liver Fibrosis: Pharmacological Evaluation, Differential Proteomics, and Network Pharmacology.肝纤维化中的Wall.ex DC:药理学评估、差异蛋白质组学和网络药理学
Front Pharmacol. 2018 May 17;9:524. doi: 10.3389/fphar.2018.00524. eCollection 2018.
3
Innate immunity: a new chapter for hepatitis C.
固有免疫:丙型肝炎的新篇章。
Ann Gastroenterol. 2012;25(3):232-240.
4
Association between inherited monogenic liver disorders and chronic hepatitis C.遗传性单基因肝脏疾病与慢性丙型肝炎之间的关联
World J Hepatol. 2014 Feb 27;6(2):92-7. doi: 10.4254/wjh.v6.i2.92.
5
Prognostic value of liver fibrosis biomarkers: a meta-analysis.肝纤维化生物标志物的预后价值:一项荟萃分析。
Gastroenterol Hepatol (N Y). 2011 Jul;7(7):445-54.